Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

IDYA IDEAYA Biosciences, Inc. Common Stock
$37.02 2.15% +0.78
Notify me if price changes either direction
Interactive Brokers Logotype

Buy IDYA stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 3.6B
Enterprise value 2.8B
Trailing PE -28.910157084465
Forward PE -10.066376
PEG Ratio -0.74826288924498
Enterprise to EBITDA -12.943
Enterprise to revenue 11.841
Price to book MRQ 3.4701912
Price to sales TTM 15.222905

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Revenue (TTM) 234.1M
EBITDA -214195008
Diluted EPS TTM -1.92
Total Cash (MRQ) 829.0M
Current ratio (MRQ) 10.451
Operating Cash Flow (TTM) -111663000

IDYA trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent IDYA News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.